Bleeding syndrome in a patient with IgA myeloma: interaction of protein and connective tissue.
D000368:Aged; D001778:Blood Coagulation Disorders / Q000150:complications* / Q000628:therapy; D001780:Blood Coagulation Tests; D001792:Blood Platelets; D001796:Blood Protein Disorders / Q000503:physiopathology*; D002118:Calcium / Q000627:therapeutic use; D003094:Collagen; D003238:Connective Tissue / Q000503:physiopathology*; D005337:Fibrin / Q000502:physiology*; D005340:Fibrinogen / Q000502:physiology*; D006474:Hemorrhagic Disorders / Q000150:complications* / Q000628:therapy; D006801:Humans; D008297:Male; D009101:Multiple Myeloma / Q000150:complications*; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use; D010956:Plasmapheresis; D011517:Prothrombin Time; D013925:Thromboplastin / Q000502:physiology; D014364:Tryptophan / Q000627:therapeutic use; D005719:gamma-Globulins / Q000502:physiology*
D009588:Nitrogen Mustard Compounds; D005719:gamma-Globulins; D014364:Tryptophan; D005337:Fibrin; D005340:Fibrinogen; D003094:Collagen; D013925:Thromboplastin; D002118:Calcium